Coverage
-
September 14, 2015
A class member in a stockholder suit over Covidien PLC and Medtronic Inc.'s proposed, $42.9 billion merger objected Friday to the nonmonetary settlement, saying it fails to benefit the class at all because it merely involves the additional disclosure of "worthless" documents.
2 other articles on this case.
View all »